Ron Bentsur
2022 - Nuvectis Pharma
In 2022, Ron Bentsur earned a total compensation of $1.7M as President & Chief Executive Officer at Nuvectis Pharma.
Compensation breakdown
Bonus | $431,250 |
---|---|
Salary | $420,360 |
Stock Awards | $842,400 |
Total | $1,694,010 |
Bentsur received $842.4K in stock awards, accounting for 50% of the total pay in 2022.
Bentsur also received $431.3K in bonus and $420.4K in salary.
Rankings
In 2022, Ron Bentsur's compensation ranked 2,011th out of 5,736 executives tracked by ExecPay. In other words, Bentsur earned more than 64.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,011 | 65th |
Manufacturing | 1,078 | 66th |
Chemicals And Allied Products | 462 | 67th |
Drugs | 424 | 68th |
Pharmaceutical Preparations | 308 | 68th |
Bentsur's colleagues
We found two more compensation records of executives who worked with Ron Bentsur at Nuvectis Pharma in 2022.